These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28937306)

  • 1. Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells.
    Pisani C; Rascol E; Dorandeu C; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Prat O
    Nanotoxicology; 2017 Sep; 11(7):871-890. PubMed ID: 28937306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing cellular uptake of mesoporous silica nanoparticles in human embryonic kidney cell line 293T cells by using Lipofectamine 2000.
    Wang J; Teng Z; Tian Y; Fang T; Ma J; Sun J; Zhu F; Wu J; Wang X; Yang N; Zhou X; Yun S; Lu G
    J Biomed Nanotechnol; 2013 Nov; 9(11):1882-90. PubMed ID: 24059087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
    Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
    ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field.
    Pisani C; Gaillard JC; Nouvel V; Odorico M; Armengaud J; Prat O
    BMC Genomics; 2015 Apr; 16(1):315. PubMed ID: 25895662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust graft-to strategy to form multifunctional and stealth zwitterionic polymer-coated mesoporous silica nanoparticles.
    Zhu Y; Sundaram HS; Liu S; Zhang L; Xu X; Yu Q; Xu J; Jiang S
    Biomacromolecules; 2014 May; 15(5):1845-51. PubMed ID: 24670217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Cellular Uptake of Silica-Coated Magnetite Nanoparticles Compared with PEG-Coated Ones in Stem Cells.
    Lee DH; Kang M; Lee HJ; Kim JA; Choi YK; Cho H; Park JK; Park TH; Jung H
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5512-9. PubMed ID: 26369110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
    He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
    Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy upregulation promotes macrophages to escape mesoporous silica nanoparticle (MSN)-induced NF-κB-dependent inflammation.
    Xi C; Zhou J; Du S; Peng S
    Inflamm Res; 2016 Apr; 65(4):325-41. PubMed ID: 26860538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
    Du X; Xiong L; Dai S; Qiao SZ
    Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
    Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
    Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.